Terns Pharmaceuticals Statistics
Total Valuation
TERN has a market cap or net worth of $705.34 million. The enterprise value is $391.03 million.
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025, after market close.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TERN has 87.51 million shares outstanding. The number of shares has increased by 20.32% in one year.
| Current Share Class | 87.51M |
| Shares Outstanding | 87.51M |
| Shares Change (YoY) | +20.32% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 0.27% |
| Owned by Institutions (%) | 60.70% |
| Float | 52.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.31 |
| P/TBV Ratio | 2.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.70, with a Debt / Equity ratio of 0.00.
| Current Ratio | 24.70 |
| Quick Ratio | 24.43 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -35.02% and return on invested capital (ROIC) is -25.15%.
| Return on Equity (ROE) | -35.02% |
| Return on Assets (ROA) | -23.97% |
| Return on Invested Capital (ROIC) | -25.15% |
| Return on Capital Employed (ROCE) | -34.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.56M |
| Employee Count | 59 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TERN has paid $254,000 in taxes.
| Income Tax | 254,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.84% in the last 52 weeks. The beta is -0.03, so TERN's price volatility has been lower than the market average.
| Beta (5Y) | -0.03 |
| 52-Week Price Change | +20.84% |
| 50-Day Moving Average | 7.61 |
| 200-Day Moving Average | 4.87 |
| Relative Strength Index (RSI) | 51.72 |
| Average Volume (20 Days) | 1,564,868 |
Short Selling Information
The latest short interest is 10.36 million, so 11.84% of the outstanding shares have been sold short.
| Short Interest | 10.36M |
| Short Previous Month | 8.23M |
| Short % of Shares Out | 11.84% |
| Short % of Float | 19.73% |
| Short Ratio (days to cover) | 9.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -105.70M |
| Pretax Income | -91.49M |
| Net Income | -91.75M |
| EBITDA | -105.48M |
| EBIT | -105.70M |
| Earnings Per Share (EPS) | -$1.04 |
Full Income Statement Balance Sheet
The company has $315.45 million in cash and $1.13 million in debt, giving a net cash position of $314.31 million or $3.59 per share.
| Cash & Cash Equivalents | 315.45M |
| Total Debt | 1.13M |
| Net Cash | 314.31M |
| Net Cash Per Share | $3.59 |
| Equity (Book Value) | 305.23M |
| Book Value Per Share | 3.49 |
| Working Capital | 306.04M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -74.36M |
| Capital Expenditures | n/a |
| Free Cash Flow | -74.36M |
| FCF Per Share | -$0.85 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TERN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.32% |
| Shareholder Yield | -20.32% |
| Earnings Yield | -13.01% |
| FCF Yield | -10.54% |
Analyst Forecast
The average price target for TERN is $13.99, which is 73.57% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.99 |
| Price Target Difference | 73.57% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -21.34% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |